Sarepta Therapeutics (SRPT) Debt Ratio: 2011-2025
Historic Debt Ratio for Sarepta Therapeutics (SRPT) over the last 14 years, with Sep 2025 value amounting to 0.31.
- Sarepta Therapeutics' Debt Ratio fell 10.08% to 0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31, marking a year-over-year decrease of 10.08%. This contributed to the annual value of 0.29 for FY2024, which is 24.34% down from last year.
- Per Sarepta Therapeutics' latest filing, its Debt Ratio stood at 0.31 for Q3 2025, which was down 0.98% from 0.31 recorded in Q2 2025.
- Over the past 5 years, Sarepta Therapeutics' Debt Ratio peaked at 0.49 during Q4 2022, and registered a low of 0.29 during Q4 2024.
- Over the past 3 years, Sarepta Therapeutics' median Debt Ratio value was 0.36 (recorded in 2024), while the average stood at 0.35.
- In the last 5 years, Sarepta Therapeutics' Debt Ratio spiked by 69.05% in 2021 and then dropped by 24.34% in 2024.
- Over the past 5 years, Sarepta Therapeutics' Debt Ratio (Quarterly) stood at 0.35 in 2021, then skyrocketed by 41.67% to 0.49 in 2022, then declined by 23.18% to 0.38 in 2023, then decreased by 24.34% to 0.29 in 2024, then decreased by 10.08% to 0.31 in 2025.
- Its last three reported values are 0.31 in Q3 2025, 0.31 for Q2 2025, and 0.33 during Q1 2025.